MCAC Will Review E-stim As Adjunctive Therapy For Wound Healing
This article was originally published in The Gray Sheet
Executive Summary
The Medicare Coverage Advisory Committee will review electrical stimulation for the treatment of chronic wounds as an adjunctive therapy, following a recommendation by the American Physical Therapy Association to the Health Care Financing Administration.
You may also be interested in...
Medtronic Incontinence Device Appears Set For Favorable MCAC Review
Medtronic's InterStim sacral nerve stimulation (SNS) device for urinary incontinence is apparently poised for the first favorable review by the Medicare Coverage Advisory Commission (MCAC), based on a technical assessment prepared by the Technology Evaluation Center (TEC) of the Blue Cross/Blue Shield Association.
HCFA non-coverage decision of electrical stimulation for wound treatment enjoined by federal court.
HCFA NON-COVERAGE OF ELECTRICAL STIMULATION FOR WOUND TREATMENT needs "a better explanation," Massachusetts federal court Judge George O'Toole declares in a Nov. 18 ruling that will require the Health Care Financing Administration to reimburse for the treatment. HCFA's decision "is so inadequately supported" by the evidence presented before the court that it justifies a new determination by the agency, according to Judge O'Toole.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.